Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Revlimid and Rituximab in untreated follicular lymphoma
NCT01145495Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jun 2010
- Primary completion
- Dec 2012
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in follicular lymphoma (FL), sponsored by National Cancer Institute. Started Jun 2010; status: completed.
02
Drugs
lenalidomide
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT01145495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01145495.